Radiographic Progression of Patients With Psoriatic Arthritis Who Achieve Minimal Disease Activity in Response to Golimumab Therapy: Results Through 5 Years of a Randomized, Placebo‐Controlled Study

OBJECTIVE: To evaluate long‐term outcomes in psoriatic arthritis (PsA) patients who achieved or did not achieve minimal disease activity (MDA) through 5 years of golimumab treatment in the GO‐REVEAL trial. METHODS: The GO‐REVEAL trial was a phase III, randomized, double‐blind trial with placebo‐cont...

Descripción completa

Detalles Bibliográficos
Autores principales: Kavanaugh, Arthur, van der Heijde, Désirée, Beutler, Anna, Gladman, Dafna, Mease, Philip, Krueger, Gerald G., McInnes, Iain B., Helliwell, Philip, Coates, Laura C., Xu, Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Psoriatic Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066795/
https://www.ncbi.nlm.nih.gov/pubmed/25779603
http://dx.doi.org/10.1002/acr.22576

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066795/
https://www.ncbi.nlm.nih.gov/pubmed/25779603
http://dx.doi.org/10.1002/acr.22576

Ejemplares similares